XML 49 R38.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Loss per Common Share - (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Schedule of Earnings Per Common Share | The following tables set forth the computation of the Company's basic and diluted loss per common share:
|  |  | Three Months Ended March 31,
(in thousands except per share amounts) |  |  |  |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |
Net income (loss) |  |  |  |  | $ | 5,193 |  |  | $ | (506) |
Less: Dividends and accretion attributable to redeemable senior preferred stockholders |  |  |  |  | (12,662) |  |  | (11,295) |
Less: Return on redeemable NCI in consolidated subsidiary |  |  |  |  | (581) |  |  | — |
Net loss attributable to common stockholders |  |  |  |  | $ | (8,050) |  |  | $ | (11,801) |
Denominator: |  |  |  |  |  |  |
Basic and diluted: |  |  |  |  |  |  |
Weighted-average common shares outstanding(1) |  |  |  |  | 78,021 |  |  | 78,133 |
Loss per common share |  |  |  |  | $ | (0.10) |  |  | $ | (0.15) |
(1)The weighted-average common shares outstanding includes 1,803,841 warrants (refer to Note 9. Redeemable Senior Preferred Stock and Warrants).
Schedule of Antidilutive Securities | Potentially anti-dilutive securities that were excluded from the Company's loss per common share are as follows:
|  |  | Three Months Ended March 31,
(in thousands) |  |  |  |  | 2024 |  | 2023
Outstanding warrants on Common Stock(1) |  |  |  |  | — |  |  | 3,557 |
Outstanding options and warrants issued to adviser(2) |  |  |  |  | — |  |  | 600 |
Restricted stock awards(3) |  |  |  |  | 1,078 |  |  | 2,245 |
Outstanding stock option awards(3) |  |  |  |  | 864 |  |  | 952 |
Total |  |  |  |  | 1,942 |  |  | 7,354 |
(1)The warrants were issued in 2018 and were exercisable at $11.50 per share. These warrants expired on August 24, 2023. (2)The warrants were issued in 2018 and were exercisable at $12.00 per share. These warrants expired on August 24, 2023. (3)Granted under the 2018 Plan.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration